Clinical Trial

DSLT Performance in Treatment-naïve Patients With Newly Diagnosed Open Angle Glaucoma

Recruiting
View on ClinicalTrials.gov →
Summary
DSLT demonstrates a ≥ 20% reduction of IOP from pre-treatment baseline in POAG patients naïve of previous glaucoma treatment at 12 months.
Trial Details
NCT Number NCT06933836
Lead Sponsor Barnet Dulaney Perkins Eye Centers
Collaborators: Alcon, a Novartis Company
Conditions Open Angle Glaucoma (OAG)
Enrollment 55 participants
Start Date 2025-03-31
Primary Completion 2027-11-30 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-04-18